| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5961058 | Heart Rhythm | 2014 | 7 Pages |
Abstract
Prevalence of AF/AFl in Brugada patients is higher than in the general population of the same age. Patients in group 1 are younger than those in group 2 and have a worse prognosis compared to both groups 2 and 3. HQ therapy has proved useful and safe in patients with AF/AFl and BrECG.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Carla MD, Natascia MD, Elena MD, Chiara MD, Davide MD, Elena MD, Daniela MD, PhD, Francesca MD, Lorella MD, Anna MD, Marco MD, Riccardo MD, Fiorenzo MD,